VeraMorph
1 known investors
VeraMorph develops proprietary oral drug delivery technology to improve the efficacy and clinical translation of poorly soluble pharmaceutical compounds. The company serves pharmaceutical companies seeking to enhance approved drug formulations and accelerate development of specialty therapeutics.
BiotechHealthtechMedical Devices